KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Curent Deferred Tax Liability Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased Short-Term Debt repayments

Nu Skin Enterprises (NUS) Receivables - Net (2016 - 2026)

Nu Skin Enterprises' Receivables - Net history spans 17 years, with the latest figure at $39.5 million for Q4 2025.

On a quarterly basis, Receivables - Net fell 22.13% to $39.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $39.5 million, a 22.13% decrease, with the full-year FY2025 number at $39.5 million, down 22.13% from a year prior.
Receivables - Net hit $39.5 million in Q4 2025 for Nu Skin Enterprises, down from $48.9 million in the prior quarter.
Over the last five years, Receivables - Net for NUS hit a ceiling of $77.3 million in Q3 2023 and a floor of $39.5 million in Q4 2025.
Historically, Receivables - Net has averaged $56.8 million across 5 years, with a median of $57.6 million in 2023.
Biggest five-year swings in Receivables - Net: crashed 34.83% in 2021 and later surged 60.97% in 2023.
Tracing NUS's Receivables - Net over 5 years: stood at $41.3 million in 2021, then grew by 14.68% to $47.4 million in 2022, then grew by 23.93% to $58.7 million in 2023, then fell by 13.48% to $50.8 million in 2024, then dropped by 22.13% to $39.5 million in 2025.
Business Quant data shows Receivables - Net for NUS at $39.5 million in Q4 2025, $48.9 million in Q3 2025, and $59.7 million in Q2 2025.